Newsroom

[Translate to English:] Dr Martin Keller.

News

The Helmholtz Association has appointed internationally respected US-based scientist Martin Keller as its new president. Following a unanimous vote by the Assembly of Members last Wednesday, the Helmholtz Senate approved the decision today. Keller has lived in the United States for nearly three decades, during which he has held various scientific leadership roles at prominent institutions. Since 2015, he has directed the National Renewable Energy Laboratory (NREL) in Golden, Colorado. His term begins on November 1, 2025.

30.10.2024

News

The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is growing: In the past three years, the institute – a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University (UdS) – has appointed five professors together with the UdS. To further strengthen the focus on active ingredients at the Saarbrücken campus, the university has filled two additional professorships in this field. To ensure that the researchers have adequate laboratory and office space, several construction projects are planned that will provide space for 330 researchers by 2029. The structural expansion is financed by federal and state development funds totaling 55.7 million euros.

29.10.2024

HIPS

News

Our immune system successfully defends itself against pathogens on a daily basis - often without us realizing it. We notice other encounters with pathogens through cold symptoms, fever or a red, swollen area. Our immune system is then working at full speed. Prof. Kathrin de la Rosa wants to be one step ahead of the pathogens. Since 2024, she has headed the department “Personalized Immunotherapy” at the Centre for Individualized Infection Medicine (CiiM) - a joint institution of Hannover Medical School and the HZI. In the HZI podcast InFact, she reports on how she wants to improve individual defense mechanisms in people whose immune system cannot cope with the pathogen on its own and explains why she is copying tricks from nature.

28.10.2024

CiiM

Angela Ittel, Josef Penninger, Frank Eggert

News

Prof. Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has been appointed honorary professor of the Faculty of Life Sciences at Technische Universität Braunschweig. The faculty honors his outstanding achievements in cell and molecular biology research, including the cloning of the SARS-CoV-2 receptor, and his outstanding ability to network scientific institutions.

22.10.2024

HZI Campus

News

Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients. A research team at the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) has now been able to produce an inactivated, harmless form of colistin that is only activated in the body with the help of chemical switches. In this so-called click-to-release technique, the chemical switches are specifically bound to the disease-causing bacteria. The administered masked colistin is therefore activated specifically at the site of action. The researchers hope that this could reduce side effects. The study was published in the journal Angewandte Chemie.

21.10.2024

HZI Campus

News

According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that 1.27 million deaths worldwide in 2019 were directly attributable to drug-resistant infections.

18.10.2024

HZI Campus

Back to the first page
...
19
20
21
22
...
150

HZI in the media

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

19.12.2025

healthcare-in-europe.com

Biosyntheseweg aufzuklären. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit ...

18.12.2025

Bionity.COM

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Korte from the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI).

The research was carried out as

12.12.2025

The Hindu

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025

Bionity.COM

Einrichtungen des regionalen Forschungsökosystems – darunter das Helmholtz-Zentrum für Infektionsforschung (HZI), das Deutsche Zentrum für

12.12.2025

EUROPE SAYS

Korte of the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI). The findings emerged from the

12.12.2025

The New Indian Express

Universität Würzburg. Seit 2018: Postdoc am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Entwicklung Bayes’scher ...

12.12.2025

BIOspektrum

Center Borstel - Leibniz Lung Center, the Helmholtz Institute for Pharmaceutical Research Saarland and other scientific institutions in

11.12.2025

Technology Networks

von Humboldt professor, head of department at the Helmholtz Centre for Infection Research, Braunschweig and full professor at the Hannover

10.12.2025

European Research Council

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.